Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Prepaid Assets: 2023-2025

Historic Prepaid Assets for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $7.3 million.

  • Immunome's Prepaid Assets rose 86.32% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 86.32%. This contributed to the annual value of $4.0 million for FY2024, which is 38.48% down from last year.
  • Per Immunome's latest filing, its Prepaid Assets stood at $7.3 million for Q3 2025, which was down 22.47% from $9.4 million recorded in Q2 2025.
  • Immunome's Prepaid Assets' 5-year high stood at $9.4 million during Q2 2025, with a 5-year trough of $773,000 in Q3 2023.
  • Its 3-year average for Prepaid Assets is $4.6 million, with a median of $4.0 million in 2024.
  • Examining YoY changes over the last 5 years, Immunome's Prepaid Assets showed a top increase of 434.32% in 2024 and a maximum decrease of 38.48% in 2024.
  • Immunome's Prepaid Assets (Quarterly) stood at $6.6 million in 2023, then crashed by 38.48% to $4.0 million in 2024, then soared by 86.32% to $7.3 million in 2025.
  • Its Prepaid Assets was $7.3 million in Q3 2025, compared to $9.4 million in Q2 2025 and $5.8 million in Q1 2025.